Login

SoftBank-Backed Biotech Company Commits to Bay Area Life Science Development

InverVenn Biosciences Preleases Entire South San Francisco Research Project
InterVenn Biosciences has preleased all 142,500 square feet at the research and development project under construction in South San Francisco, California. (CoStar)
InterVenn Biosciences has preleased all 142,500 square feet at the research and development project under construction in South San Francisco, California. (CoStar)
CoStar News
May 17, 2022 | 12:30 AM

A fast-growing San Francisco Bay Area biotech firm has swooped in to stake its claim on a building still more than a year away from completing construction.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE


News | SoftBank-Backed Biotech Company Commits to Bay Area Life Science Development